Apogee Therapeutics Stock (NASDAQ: APGE) stock price, news, charts, stock research, profile.
Open | $48.99 |
Close | $49.21 |
Volume / Avg. | 490.03K / 459.56K |
Day Range | 47.69 - 50.61 |
52 Wk Range | 14.19 - 72.29 |
Market Cap | $2.77B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 66 |
Short Interest | 20.83% |
Days to Cover | 10.4 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Apogee Therapeutics (NASDAQ:APGE) through any online brokerage.
Other companies in Apogee Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX), PTC Therapeutics (NASDAQ:PTCT) and TG Therapeutics (NASDAQ:TGTX).
There is no analysis for Apogee Therapeutics.
Apogee Therapeutics has a consensus price target of $70.67.
The stock price for Apogee Therapeutics (NASDAQ: APGE) is $49.21 last updated Today at July 17, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Apogee Therapeutics.
Apogee Therapeutics’s Q2 earnings are confirmed for Monday, August 26, 2024.
There is no upcoming split for Apogee Therapeutics.
Apogee Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.